Diagnostics, closer to the point of care

Sensitive diagnostics,
built for the point of care.

Femtova Dx is developing a portable testing platform for low-concentration biomarker detection, with HIV-1 p24 as its model system.

A point-of-care lateral flow assay platform in development

01 ASSAY STRIP
02 PORTABLE READER
Scroll to explore

The opportunity

Bring sensitive detection
closer to the decision.

01 / 04

Many testing pathways rely on centralized laboratory workflows. We are developing tools that bring biomarker detection closer to the point of care.

The platform

One platform.
Room to adapt.

A lateral flow assay format paired with a portable reader. Designed around practical detection needs and a path toward additional biomarkers.

01

Sensitive

The platform is designed to detect targets at very low concentrations. HIV-1 p24 is the current model system.

TARGET DETECTION

The platform is designed to detect targets at very low concentrations. HIV-1 p24 is the current model system.

02

Portable

A compact reader prototype is being developed alongside the lateral flow assay.

READER PROTOTYPE

A compact reader prototype is being developed alongside the lateral flow assay.

03

Adaptable

The platform has a multiplex biomarker direction, with additional targets to be defined through future research.

PLATFORM DIRECTION

The platform has a multiplex biomarker direction, with additional targets to be defined through future research.

Platform under development. No clinical or regulatory claims are made.

Build with us

Good science moves
through collaboration.

We are looking for collaborators who share our goal of advancing point-of-care diagnostics.

Start a conversation
01

Diagnostics companies

Co-development and licensing

02

Research and clinical partners

Study design and validation

03

Funders

Grant and investment partners

The people

Built by people
who care about the details.

A founding team building at the intersection of diagnostics, engineering, and research.

Dr. Evan ReboliFOUNDING TEAM

Dr. Evan Reboli

Chief Executive Officer and Co-founder

01

Biography to be provided.

Dr. Suri IyerFOUNDING TEAM

Dr. Suri Iyer

Chief Scientific Officer and Co-founder

02

Biography to be provided.

Governance

Board of
directors.

01 / TBD

Board composition to be confirmed

Director names and biographies will be added after approval.

Contact

Have a question
or an idea?

Interested in working with us? Send a note to start a conversation.

Contact details to be confirmed
We will share a response-time commitment once confirmed.

Contact email and form delivery are not configured yet. Your message will not be sent.